pubmed-article:8849376 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8849376 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:8849376 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
pubmed-article:8849376 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:8849376 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:8849376 | lifeskim:mentions | umls-concept:C0391754 | lld:lifeskim |
pubmed-article:8849376 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
pubmed-article:8849376 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:8849376 | pubmed:dateCreated | 1996-10-24 | lld:pubmed |
pubmed-article:8849376 | pubmed:abstractText | To determine the safety and efficacy of recombinant soluble human interleukin-1 receptor type I (rHuIL-1RI) administered subcutaneously in patients with active rheumatoid arthritis (RA). | lld:pubmed |
pubmed-article:8849376 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8849376 | pubmed:language | eng | lld:pubmed |
pubmed-article:8849376 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8849376 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8849376 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8849376 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8849376 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8849376 | pubmed:month | Feb | lld:pubmed |
pubmed-article:8849376 | pubmed:issn | 0004-3591 | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:SinacoreJ MJM | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:PopeR MRM | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:JacobsCC | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:LandayAA | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:MorelandL WLW | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:LovisRR | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:DrevlowB EBE | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:HaagM AMA | lld:pubmed |
pubmed-article:8849376 | pubmed:author | pubmed-author:BloscheCC | lld:pubmed |
pubmed-article:8849376 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8849376 | pubmed:volume | 39 | lld:pubmed |
pubmed-article:8849376 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8849376 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8849376 | pubmed:pagination | 257-65 | lld:pubmed |
pubmed-article:8849376 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:meshHeading | pubmed-meshheading:8849376-... | lld:pubmed |
pubmed-article:8849376 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8849376 | pubmed:articleTitle | Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. | lld:pubmed |
pubmed-article:8849376 | pubmed:affiliation | Northwestern University and the Veterans Affairs Lakeside Medical Center, Chicago, IL 60611, USA. | lld:pubmed |
pubmed-article:8849376 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8849376 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8849376 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:8849376 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:8849376 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:8849376 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:8849376 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8849376 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8849376 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8849376 | lld:pubmed |